The 2019 Medicare Part D Changes for Persons Who Have Both Medicare and Medicaid (The Dual Eligibles) Webinar
Beginning on January 1, 2019, there will be some changes in Medicare Part D, the federal drug benefit that is used by most dual eligibles (persons who have both Medicaid and Medicare) to obtain their prescription medications.
This webinar is for everyone who wants to know about Medicare Part D for the dual eligibles, including employees of provider agencies serving people with Intellectual and Developmental Disabilities (I/DD), staff from DDD, family members, and health care professionals. The webinar discussed the details of the changes and how they will affect individuals with developmental disabilities who are eligible for both Medicare and Medicaid.
- The Arc Slides
- SHIP Slides
- 2019 Benchmark Drug Plans for NJ
- All 2019 Medicare Part D Stand-Alone Drug Plans in New Jersey
- Full list of county SHIP offices
FAQ's for Individuals who have both Medicaid & Medicare
Some individuals with intellectual and developmental disabilities (I/DD) are dual eligibles because they receive both Medicare and Medicaid. The Arc of New Jersey's Mainstreaming Medical Care Program is distributing information in the form of Frequently Asked Questions (FAQs) to respond to the questions that families have been asking. The questions and answers are divided into three sections. Click below to see the FAQs.
"Understanding what happens when a person with I/DD who receives Medicaid becomes eligible for Medicare."
The Dual Eligibles: Persons with Intellectual and Developmental Disabilities (I/DD) Who Have Both Medicaid and Medicare
This webinar provides information to help families and staff understand why so many persons with I/DD are dually eligible for both Medicaid and Medicare. The webinar explains the ways that dual eligibles can access health care services, including prescription drugs. Some individuals with I/DD have private health insurance in addition to Medicaid and Medicare, and the webinar will also address this issue.
Presented on December 13, 2017